Binding of Integrin α6β4 to Plectin Prevents Plectin Association with F-Actin but Does Not Interfere with Intermediate Filament Binding by Geerts, Dirk et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/99/10/417/18 $5.00
The Journal of Cell Biology, Volume 147, Number 2, October 18, 1999 417–434
http://www.jcb.org 417
 
Binding of Integrin 
 
a
 
6
 
b
 
4 to Plectin Prevents Plectin Association with
F-Actin but Does Not Interfere with Intermediate Filament Binding
 
Dirk Geerts,* Lionel Fontao,* Mirjam G. Nievers,* Roel Q.J. Schaapveld,* Patricia E. Purkis,
 
‡
 
Grant N. Wheeler,
 
§
 
 E. Birgitte Lane,
 
§
 
 Irene M. Leigh,
 
‡ 
 
and Arnoud Sonnenberg*
 
*Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; 
 
‡
 
Skin Tumour Laboratory, 
Imperial Cancer Research Fund, St. Bartholomew and the Royal London School of Medicine and Dentistry, Queen Mary and 
Westﬁeld College, Clinical Sciences Research Centre, London E1 2AT, United Kingdom; and 
 
§
 
Cancer Research Campaign Cell 
Structure Research Group, Cancer Research Campaign Laboratories, Department of Anatomy and Physiology, Medical Science 
Institute/Wellcome Trust Building Complex, University of Dundee, Dundee DD15 EH, United Kingdom
 
Abstract. 
 
Hemidesmosomes are stable adhesion com-
plexes in basal epithelial cells that provide a link be-
tween the intermediate ﬁlament network and the extra-
cellular matrix. We have investigated the recruitment of 
plectin into hemidesmosomes by the 
 
a
 
6
 
b
 
4 integrin and 
have shown that the cytoplasmic domain of the 
 
b
 
4 sub-
unit associates with an NH
 
2
 
-terminal fragment of plec-
tin that contains the actin-binding domain (ABD). 
When expressed in immortalized plectin-deﬁcient
keratinocytes from human patients with epidermol-
ysis bullosa (EB) simplex with muscular dystrophy
(MD-EBS), this fragment is colocalized with 
 
a
 
6
 
b
 
4 in 
basal hemidesmosome-like clusters or associated with 
F-actin in stress ﬁbers or focal contacts. We used a yeast 
two-hybrid binding assay in combination with an in 
vitro dot blot overlay assay to demonstrate that 
 
b
 
4 in-
teracts directly with plectin, and identiﬁed a major plec-
tin-binding site on the second ﬁbronectin type III re-
peat of the 
 
b
 
4 cytoplasmic domain. Mapping of the 
 
b
 
4 
and actin-binding sites on plectin showed that the bind-
 
ing sites overlap and are both located in the plectin 
ABD. Using an in vitro competition assay, we could 
show that 
 
b
 
4 can compete out the plectin ABD frag-
ment from its association with F-actin. The ability of
 
b
 
4 to prevent binding of F-actin to plectin explains why 
F-actin has never been found in association with 
hemidesmosomes, and provides a molecular mecha-
nism for a switch in plectin localization from actin ﬁla-
ments to basal intermediate ﬁlament–anchoring 
hemidesmosomes when 
 
b
 
4 is expressed. Finally, by 
mapping of the COOH-terminally located binding site 
for several different intermediate ﬁlament proteins on 
plectin using yeast two-hybrid assays and cell transfec-
tion experiments with MD-EBS keratinocytes, we con-
ﬁrm that plectin interacts with different cytoskeletal 
networks.
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H
 
EMIDESMOSOMES
 
 are junctional protein complexes
that stably bind basal epithelial cells to the base-
ment membrane in (pseudo)stratified and some
complex epithelia. They are essential for a tight link be-
tween the intracellular intermediate filament system and pro-
teins of the extracellular matrix. Hemidesmosomes consist
of at least four distinct proteins. Two of these, the integrin
 
a
 
6
 
b
 
4 and the bullous pemphigoid antigen 180 (BP180)
 
1
 
,
are transmembrane proteins that are involved in anchor-
ing the basal epithelial cells to the underlying basement
membrane. The hemidesmosomal plaque proteins, BP230
and plectin, are localized in the cytoplasm, and play a
major role in the binding of intermediate filaments to
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1. 
 
Abbreviations used in this paper:
 
 ABD, actin-binding domain; ABS, ac-
tin-binding site; AD, activation domain; AGB, actin-G buffer; APB, actin
polymerization buffer; BD, binding domain; BP, bullous pemphigoid anti-
gen; CS, connecting segment; EB, epidermolysis bullosa; HA, hemaggluti-
nin; IFBD, intermediate filament binding site; MD-EBS, muscular dystro-
phy associated with EB simplex; FNIII, fibronectin type III; GAL4,
galactose metabolism regulatory gene 4; GFAP, glial fibrillary acidic pro-
tein; GST, glutathione 
 
S
 
-transferase; MBP, maltose-binding protein;
NHK, normal human keratinocytes; PA-JEB, pyloric atresia associated
with junctional EB; SC, synthetic complete medium. 
The Journal of Cell Biology, Volume 147, 1999 418
 
hemidesmosomes (Borradori and Sonnenberg, 1996; Green
and Jones, 1996; Burgeson and Christiano, 1997).
The 
 
a
 
6
 
b
 
4 integrin binds to several laminins, particularly
the major basement membrane component laminin-5
(Niessen et al., 1994). It is prominently expressed in strati-
fied and complex epithelia, in which it is present only in
hemidesmosomes (Kajiji et al., 1989; Stepp et al., 1990;
Sonnenberg et al., 1991). The 
 
a
 
6
 
b
 
4 integrin has a central
role in the assembly and maintenance of hemidesmo-
somes, as demonstrated by the severe nature of the disease
pyloric atresia associated with junctional epidermolysis
bullosa (EB) (PA-JEB), which is caused by the absence of
 
a
 
6 or 
 
b
 
4. PA-JEB patients suffer from extensive blistering
of the skin due to the absence of functional hemidesmo-
somes (Vidal et al., 1995; Ruzzi et al., 1997). A similar skin
phenotype occurs in mice in which the gene encoding 
 
a
 
6
or 
 
b
 
4 had been disrupted by homologous recombination
(Dowling et al., 1996; Georges-Labouesse et al., 1996; van
der Neut et al., 1996).
Essential for the role of 
 
a
 
6
 
b
 
4 in hemidesmosome assem-
bly is the unique cytoplasmic domain of the 
 
b
 
4 subunit. It
is over 1,000 amino acid residues in length, and contains
two pairs of fibronectin type III (FNIII) repeats separated
by a connecting segment (CS) (Hogervorst et al., 1990; Su-
zuki and Naitoh, 1990). Specifically, sequences within the
first and second FNIII repeats and in the CS are important
for the formation of a complex with plectin and its recruit-
ment into hemidesmosomes at the basal surface of the cell
(Spinardi et al., 1993; Niessen et al., 1997a; Nievers et al.,
1998). Fusion proteins containing the first two FNIII re-
peats and part of the CS of 
 
b
 
4 form a complex with plectin
in vitro (Niessen et al., 1997b), and recombinant 
 
b
 
4 pro-
tein fragments containing these sequences were found to
bind plectin in in vitro assays (Rezniczek et al., 1998). The
CS and third FNIII repeat are essential for association
with the BP180 protein (Borradori et al., 1997; Aho and
Uitto, 1998; Schaapveld et al., 1998). Therefore, the 
 
a
 
6
 
b
 
4
integrin clearly has a structural role, but it is also involved
in the transduction of cell adhesion–modulating signals
(for reviews see Giancotti, 1996; Borradori and Sonnen-
berg, 1999; Nievers et al., 1999).
The BP180 protein (BPAG2), a type II transmembrane
protein, is only expressed in epithelial tissues (Nishizawa
et al., 1993; Aho and Uitto, 1999), and is probably also a
receptor for laminin-5 (Reddy et al., 1998). BP180 is
recruited into hemidesmosomes by direct binding to the
 
b
 
4 cytoplasmic domain (Borradori et al., 1997, 1998;
Schaapveld et al., 1998; see also Hopkinson et al., 1995,
1998), and there is data suggesting that it is also involved
in the recruitment of BP230 to hemidesmosomes (Borra-
dori et al., 1998).
The two hemidesmosomal plaque proteins, BP230 and
plectin, belong to the plakin family, which is widely ex-
pressed cytoskeleton-associated proteins (Ruhrberg and
Watt, 1997). BP230 (BPAG1) is predominantly expressed
in stratified and some complex epithelia. The COOH ter-
minus of BP230 was found to decorate intermediate fila-
ment networks in vivo and to bind intermediate filament
proteins in vitro (Yang et al., 1996; Leung et al., 1999), but
the function of its NH
 
2
 
 terminus remains unknown. Vari-
ant BPAG1 proteins (dystonins) exist that are only ex-
pressed in neuronal tissue. These contain an NH
 
2
 
-terminal
actin-binding domain (ABD) as a result of alternative
mRNA splicing (Brown et al., 1995; Guo et al., 1995; Yang
et al., 1996).
The large plectin protein (
 
z
 
500 kD) is the most widely
expressed member of the plakin family (for review see
Wiche, 1998). It belongs to the spectrin superfamily of ac-
tin-binding proteins (like dystonin) that share a conserved
ABD, itself a tandem duplication of the calponin homol-
ogy domain (Hartwig, 1994; Van Troys et al., 1999). Three
conserved actin-binding sequences (ABS 1–3) have been
identified within the ABD (Hemmings et al., 1992; Fab-
brizio et al., 1993; Corrado et al., 1994). The 
 
PLEC1
 
 gene
contains alternative first coding exons, and the resulting
plectin splice variants show a characteristic tissue expres-
sion. The sequence encoding the ABD is present in all
plectin mRNAs (Liu et al., 1996; McLean et al., 1996; El-
liott et al., 1997). Indeed, plectin is found in association
with actin stress fibers and focal contacts (Seifert et al.,
1992; Sánchez-Aparicio et al., 1997). Recently, it was
shown that NH
 
2
 
-terminal plectin fragments containing the
ABD associate with F-actin stress fibers in vivo in trans-
fected plectin-deficient fibroblasts and bind monomeric
(G-)actin in vitro. Furthermore, plectin might be involved
in the regulation of actin filament dynamics via phosphati-
dylinositol 4,5-bisphosphate (PIP2) (Andrä et al., 1998).
The COOH-terminal part of plectin contains six tandem
repeat domains (R1–R6) that bind to, or can codistribute
with, several types of intermediate filament proteins; epi-
dermal keratins, vimentin, desmin and GFAP (glial fibril-
lary acidic protein), the neurofilament triplet proteins, and
lamin B (for review see Wiche, 1998). The intermediate
filament binding site (IFBD) on plectin was mapped to a
region of 
 
z
 
50 amino acids at the end of the fifth repeat,
R5 (Nikolic et al., 1996). In addition to actin and interme-
diate filaments, there is evidence for an interaction of plec-
tin with microtubules (Herrmann and Wiche, 1987; Svit-
kina et al., 1996), suggesting that it can interlink all three
major protein cytoskeletal systems (Wiche, 1998). The
functional importance of plectin is demonstrated by the
fact that mutations in the 
 
PLEC1
 
 gene cause muscular
dystrophy associated with EB simplex (MD-EBS), a dis-
ease characterized by skin blistering and skeletal muscle
myopathies (Gache et al., 1996; McLean et al., 1996; Smith
et al., 1996). A similar phenotype was seen in null-mutant
mice in which the 
 
PLEC1
 
 gene had been disrupted (An-
drä et al., 1997). There is ample evidence for an associa-
tion of plectin with the integrin 
 
b
 
4 subunit within the
hemidesmosome (see references above), and there are
some indications that plectin can associate with BP180 and
thereby influence BP180 localization (Gache et al., 1996;
Aho and Uitto, 1997; Schaapveld et al., 1998).
In this study, we have investigated the role of plectin in
the formation of hemidesmosomes. Firstly, we wished to
understand why F-actin has not been found in hemidesmo-
somes, even though plectin contains a spectrin-like ABD,
and why 
 
b
 
4, which can form a complex with plectin, is
never found in association with the actin cytoskeleton.
Secondly, we endeavored to show that the recruitment of
plectin into hemidesmosomes by 
 
b
 
4 is the result of a direct
interaction between plectin and the 
 
b
 
4 cytoplasmic do-
main, and if this could be established, the location of the
binding sites on these proteins could be determined. Our 
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third aim was to investigate the relation between the bind-
ing of plectin to 
 
b
 
4 and intermediate filaments. The re-
cruitment of plectin into hemidesmosomes, and the func-
tion of its NH
 
2
 
-terminal ABD and COOH-terminal IFBD
sequences was, for the first time, studied in the absence of
endogenous plectin in MD-EBS keratinocytes. We dem-
onstrate that plectin molecules associate in a mutually
exclusive manner with either actin filaments or 
 
b
 
4 in
hemidesmosomes as a result of competitive binding. In
addition, we show which intermediate filament proteins
are capable of directly binding to the plectin-IFBD and
thereby present further evidence for the versatility of plec-
tin as a cytoskeletal linker protein.
 
Materials and Methods
 
Generation of Immortalized MD-EBS Keratinocytes
 
Skin punch biopsies (4 mm in diameter) were removed from the trunk of
two unrelated patients diagnosed with MD-EBS and transported to the
laboratory in transport medium (DMEM containing the following antibi-
otics: 0.01% (wt/vol) streptomycin, 0.01% (wt/vol) penicillin, and 2.5 U/ml
fungisone). The tissue was cut into several pieces and incubated in 0.5%
(wt/vol) trypsin, 0.1% (wt/vol) EDTA for 90 min at 37
 
8
 
C to separate the
epidermis from the dermis. The epidermal sheets were reincubated in
fresh trypsin/EDTA at 37
 
8
 
C for 5 min, pipetted vigorously to encourage
basal cell detachment, after which trypsinization was arrested by the addi-
tion of DMEM containing 10% FCS, and the resulting cell suspensions
were centrifuged. The keratinocyte suspension was plated into two T25
flasks (Greiner) together with 5 
 
3
 
 10
 
5
 
 irradiated 3T3 feeder cells and ke-
ratinocyte medium (Rheinwald and Green, 1975) without EGF. Cells
were checked and medium (keratinocyte medium with EGF) changed
twice weekly. At 80% confluence, cells were trypsinized, split at 1:5, and
replated with fresh 3T3 feeder cells.
At passage two, cells were plated in T25 flasks with irradiated 3T3
feeder cells and allowed to grow to 40–50% confluence. The medium was
changed to keratinocyte growth medium, a low calcium medium (0.15 mM
Ca
 
2
 
1
 
), with 10 ng/ml EGF, 5 
 
m
 
g/ml insulin, 0.5 U/ml hydrocortisone, and
0.4% (vol/vol) bovine pituitary extract (Clonetics Corp.) for 48 h, thus al-
lowing cells to spread out as a monolayer. The human papillomavirus 16
expression plasmid pJ4
 
V
 
16 (Storey et al., 1988) used for the immortaliza-
tion was a gift from Dr. A. Storey (Molecular Virology Laboratory, ICRF,
London, United Kingdom). For transfection, keratinocytes were washed
once with OPTI-MEM (GIBCO BRL) and 4 ml OPTI-MEM was added
to each flask and incubated at 37
 
8
 
C
 
 
 
for 4 h. For each T25 flask, the follow-
ing solutions were prepared and incubated for 30 min at room tempera-
ture before mixing: solution A, 10 
 
m
 
g DNA (human papillomavirus 16
plasmid) in 0.5 ml OPTI-MEM; and solution B, 30 
 
m
 
l Lipofectin (18292-
011; GIBCO BRL) in 1.5 ml OPTI-MEM. The two solutions were com-
bined, mixed gently, and incubated for a further 10–15 min. All medium
was removed from the flasks and 2 ml of transfection mixture was added.
The cells were incubated overnight at 37
 
8
 
C, and the next day 4 ml kerati-
nocyte medium and fresh irradiated 3T3 feeder cells were added. Medium
was changed twice a week, and cultures were split at 80% confluence.
After transfection, keratinocytes grew for one or two passages and then
entered a growth crisis for a period of up to 12 wk. After this crisis, colo-
nies growing from single cells were cloned using cloning rings (C-1059;
Sigma Chemical Co.), and then passaged using the same medium. Two
MD-EBS cell lines (PEB-1 and 2) were used in this study.
 
Cell Lines and Antisera
 
Immortalized normal human keratinocytes (NHK) from foreskin and the
immortalized 
 
b
 
4-deficient PA-JEB keratinocyte cell line were described
previously (Steenbergen et al., 1996; Schaapveld et al., 1998). Immortalized
NHK, PA-JEB, and MD-EBS keratinocytes were grown in keratinocyte
serum-free medium (GIBCO BRL) supplemented with 50 
 
m
 
g/ml bovine
pituitary extract, 5 ng/ml EGF, 100 U/ml penicillin, and 100 U/ml strepto-
mycin. Cells were grown at 37
 
8
 
C in a humidified, 5% CO
 
2
 
 atmosphere.
The MD-EBS and PA-JEB keratinocytes were transiently transfected
with cDNA constructs using Lipofectin (GIBCO BRL) according to the
manufacturer’s procedure.
Rabbit polyclonal antisera against 
 
a
 
6 and 
 
b
 
4 have been described pre-
viously (Hogervorst et al., 1993; Niessen et al., 1994). Mouse mAb 58XB4
against 
 
b
 
4 was prepared by Dr. A.M. Martínez de Velasco and Mr. D.
Kramer in our laboratory. Mouse mAbs 450-11A (Kennel et al., 1990) and
4.3E1 (Hessle et al., 1984) against 
 
b
 
4 were kind gifts of Dr. S.J. Kennel
(Oak Ridge National Laboratory, Oak Ridge, TN) and Dr. E. Engvall
(The Burnham Institute, La Jolla, CA), respectively. Mouse mAb 233
(Nishizawa et al., 1993) against BP180 and mouse mAb 121 (Hieda et al.,
1992) against plectin/HD1 were kind gifts of Dr. K. Owaribe (University
of Nagoya, Nagoya, Japan). Rabbit polyclonal antiserum against BP180
was kindly provided by Dr. L. Bruckner-Tuderman (University of Mün-
ster, Münster, Germany). The rabbit polyclonal antiserum recognizing
BP230 (Tanaka et al., 1990) was a kind gift from Dr. J.R. Stanley (Univer-
sity of Pennsylvania, Philadelphia, PA). Polyclonal antibodies against
plectin were generated by immunizing rabbits with a glutathinone 
 
S
 
-trans-
ferase (GST) fusion protein containing the NH
 
2
 
-terminal domain of plec-
tin (residues 1–339). The antibodies were purified by affinity chromatog-
raphy on a plectin (1–339)/maltose-binding protein (MBP) Sepharose
column. Mouse mAb 6F12, also known as BM-140 (Marinkovich et al.,
1992), against laminin-5, was a kind gift from Dr. R.E. Burgeson (Cutane-
ous Biology Research Center, Charlestown, MA). Mouse mAb 7A8
against plectin was purchased from Sigma Chemical Co. Mouse mAbs V9
against vimentin and KL1, recognizing a broad spectrum of keratins, were
purchased from Coulter/Immunotech. Mouse mAb SPK-14 against kera-
tin 14 was a kind gift from Dr. D. Ivanyi (Division of Tumor Biology, The
Netherlands Cancer Institute, Amsterdam, The Netherlands). Mouse
mAb 12C05 and rabbit polyclonal antiserum HA-11 against the hemag-
glutinin (HA) epitope (YPYDVPDYA) were purchased from Santa Cruz
Biotechnology. Sheep anti–mouse and donkey anti–rabbit HRP-coupled
secondary antisera, and donkey anti–rabbit Texas Red conjugated anti-
sera were purchased from Amersham Pharmacia Biotech, and FITC-con-
jugated goat anti–mouse antiserum from Rockland.
 
Western Blotting
 
MD-EBS keratinocytes were plated in 6-well tissue culture plates and
lysed in 80 
 
m
 
l sample buffer. Lysates were boiled for 5 min at 95
 
8
 
C, and 40
 
m
 
l samples analyzed by SDS-PAGE. After electrophoresis, proteins were
transferred to polyvinylidene difluoride membrane (Immobilon-P; Milli-
pore) and blots were blocked in 2% (wt/vol) baby milk powder in TBST
(10 mM Tris-HCl, pH 7.4, 100 mM NaCl, 0.01% [vol/vol] Tween 20) for 1 h
at 37
 
8
 
C. Subsequently, blots were incubated with primary antisera in 0.2%
(wt/vol) baby milk powder in TBST for 1 h at room temperature. After
extensive washing, blots were incubated for 1 h at room temperature with
secondary HRP-coupled antisera in the same buffer as used for the pri-
mary antiserum incubation. Proteins were detected using the chemilumi-
nescence procedure (Amersham Pharmacia Biotech) according to the
manufacturer’s instructions.
 
Immunofluorescence
 
MD-EBS and PA-JEB keratinocytes were switched to HAMF12/DMEM
(1:3) containing 10% (vol/vol) FCS, 2 mM L-glutamine, 0.4 
 
m
 
g/ml hydro-
cortisone (Sigma Chemical Co.), and 1 
 
m
 
M isoproterenol (Sigma Chemi-
cal Co.) 24 h before the immunolabeling procedure was started. Kerati-
nocytes grown on glass coverslips were washed twice with PBS (pH 7.2),
and fixed for 10 min at room temperature in freshly prepared 1% (wt/vol)
paraformaldehyde in PBS. Fixed cells were washed twice with PBS and
permeabilized in 0.5% (vol/vol) Triton X-100 in PBS for 5 min at room
temperature. Cells were rinsed and incubated in 2% (wt/vol) BSA in PBS
for 30 min at room temperature, washed with PBS, and incubated with
primary antisera or TRITC-conjugated phalloidin in PBS containing 2%
BSA for 30 min at 37
 
8
 
C. After washing with PBS, cells were incubated
with the secondary antiserum, goat anti–mouse–FITC or donkey anti–rab-
bit–Texas red diluted 1:100 in PBS containing 2% BSA. After rinsing in
PBS, the preparations were mounted in Vectashield (Vector Laboratories
Inc.) and viewed under a BioRad MRC-600 confocal laser scanning micro-
scope.
 
cDNA Constructs
 
All nucleotide and amino acid positions are numbered with the ATG initi-
ation codon at position one. Plasmid inserts were generated by PCR using
the proofreading 
 
Pwo 
 
DNA polymerase (Boehringer Mannheim) and
gene-specific sense and antisense primers containing restriction site tags. 
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All plasmid inserts were confirmed by sequence analysis using the
 
T7
 
Sequencing kit (Amersham Pharmacia Biotech).
Plectin-ABD, a clone containing alternative exon 1c, exons 2–8, and
almost the complete exon 9 of human epithelial plectin cDNA (position
1–1018), and plectin-IFBD (see below) were inserted into pcDNA3HA (a
kind gift from Dr. E. Sander, Division of Cell Biology, The Netherlands
Cancer Institute, Amsterdam, The Netherlands), a derivative of the eu-
karyotic expression vector pcDNA3 (Invitrogen Corp.) that contains an
extra sequence 5
 
9
 
 of the multiple cloning site encoding the HA tag.
The yeast galactose metabolism regulatory gene 4 (GAL4) plasmids
containing human 
 
b
 
4 (sequence data available from EMBL/GenBank/
DDBJ under accession nos. X51841 and X52186), human epithelial plec-
tin (U53204), and mouse plectin (rat accession number X59601) cDNA
subclones and full-length cDNA encoding human 
 
a
 
 skeletal muscle actin
(J00068), human 
 
b
 
 cytoplasmic actin (AB004047), human 
 
g
 
 cytoplasmic
actin (M19283), human keratin 5 (M28496), human keratin 8 (M34225),
human keratin 14 (J00124), human keratin 18 (M26326), human GFAP
(S40719), and mouse vimentin (M26251) are described in Figs. 5, 7, and 9.
Numbers in superscript correspond to the amino acid residues of sub-
clones encoded within the GAL4 activation domain (AD) or binding do-
main (BD) fusion proteins. Vectors used were the yeast GAL4 AD or BD
expression vectors pACT2 or pAS2-1 (Clontech). The template DNAs
used for PCR were full-length cDNAs encoding human 
 
b
 
4, human 
 
a
 
 skel-
etal muscle actin, mouse vimentin, human plectin (kind gifts from Dr. T.
Magin, Institut für Genetik, University of Bonn, Bonn, Germany), human
keratins 5, 8, 14, and 18, and cDNA subclones containing bps 1–1018,
2377–3156, and 13054–13725 of human epithelial plectin. Other templates
used were EST clones obtained from the IMAGE cDNA clone collection
at the Resource Center/Primary Database of the German Human Ge-
nome Project (RZPD, Berlin, Germany): 975524 and 1064756 for mouse
and 52195 for human plectin 3
 
9
 
 clones; 361338, 364065, and 381924 for hu-
man GFAP; 611141 and 613287 for human 
 
b
 
 cytoplasmic actin; and 41909
and 362511 for human 
 
g
 
 cytoplasmic actin.
The full-length 
 
b
 
4 cDNA construct in the eukaryotic expression vector
pRc/CMV (Invitrogen Corp.) has been described previously (Niessen et al.,
1997a,b). The CGG to TGG mutation in codon 1281 of 
 
b
 
4, a human pa-
tient mutation that results in an R to W amino acid substitution at position
1281 (Pulkkinen et al., 1998), was introduced into human 
 
b
 
4 cDNA by se-
quence overhang extension PCR. The mutagenesis primers 5
 
9
 
-GACAAC-
CCTAAGAACTGGATGCTGCTTATTG-3
 
9
 
 (sense) and 5
 
9
 
-CAATAA-
GCAGCATCCAGTTCTTAGGGTTGTC-3
 
9
 
 (antisense), representing
positions 3826–3856 of the human 
 
b
 
4 coding sequence, were used with
normal human 
 
b
 
4 cDNA as a template. The resulting DNA fragments
were first cloned into the pACT2 vector, verified by DNA sequencing,
and used in yeast two-hybrid analysis (see Fig. 5 B). For cell transfection
experiments, the mutation was subsequently introduced into full-length
 
b
 
4 cDNA in pRc/CMV by exchanging of the appropriate DNA restriction
fragments (see Fig. 6).
DNA fragments encoding different fragments of the 
 
b
 
4 cytoplasmic
domain were isolated from pACT2-
 
b
 
4 plasmids (described above) and
cloned into the bacterial GST fusion protein expression vector pRP261, a
derivative of the pGEX-3X vector (Amrad Corp. Ltd.) that contains a
slightly modified multiple cloning site, for the production of recombinant
GST fusion proteins (see Fig. 8).
Plectin-ABD was isolated from pcDNA3HA-plectin ABD (described
above) and inserted into the bacterial MBP fusion protein expression vec-
tor pMAL-c2X (New England Biolabs Inc.), for the production of MBP
fusion proteins (see Fig. 8).
The 
 
b
 
4 cDNA expression constructs used for the experiments in Fig. 11
have been described previously (Niessen et al., 1997a,b).
 
Yeast Two-Hybrid Assay
 
Yeast strain 
 
Saccharomyces cerevisiae
 
 PJ69-4A (a gift from Dr. P. James,
Department of Biomolecular Chemistry, University of Wisconsin, Madi-
son, WI), which contains the genetic markers trp1-901, leu2-3, his3-200,
gal4
 
D
 
, gal80
 
D
 
, LYS2::GAL1-HIS3, GAL2-ADE2 (James et al., 1996), was
used as the host for the two-hybrid assay. It contains two tightly regulated
reporter genes, His and Ade, which makes it suitable for the sensitive de-
tection of protein interactions. The use of PJ69-4A was essentially as de-
scribed in Schaapveld et al. (1998). In brief, PJ69-4A cells were cotrans-
formed with a pACT2(-derived) as well as a pAS2-1(-derived) plasmid,
and aliquots of the same transformation mixture were spread on plates
containing SC-LT medium, yeast synthetic complete medium (SC) lacking
only the vector markers Leu (for pACT2 and derivatives) and Trp (for
 
pAS2-1 and derivatives), as well as on SC-LTHA plates, lacking Leu, Trp,
as well as the interaction markers His and Ade. Plates were scored after 6
and 12 d of growth, and the number of colonies on the SC-LTHA plate
compared with that on the SC-LT plate. Positive and negative controls
used were as in Schaapveld et al. (1998). Cotransformation efficiencies
(on nonselective SC-LT plates) for all plasmid combinations were always
at least 10
 
4 
 
cfu/
 
m
 
g plasmid DNA, and the difference between the various
plasmid combinations tested was never greater than twofold. Cotransfor-
mation of yeast PJ69-4A with an empty pAS2-1 and an empty pACT2 vec-
tor, with a derived pAS2 plasmid and an empty pACT2 vector, or with an
empty pAS2 vector and a derived pACT2 plasmid never resulted in the
growth of colonies on selective SC-LTHA plates, showing that none of the
GAL4 fusion proteins encoded by the recombinant plasmids used could
cause activation of the His and Ade reporter genes by themselves. For
pACT2-
 
b41457–1752, –keratin 5, and –keratin 8 constructs, a slight autono-
mous activation of the reporter genes was found, but this could be re-
pressed by the addition of 2 mM 3-amino-1,2,4-triazole (a His antagonist)
(A8506; Sigma Chemical Co.) to the medium.
Purification of Recombinant Fusion Proteins
Escherichia coli strain BL21(DE3), genotype F2 ompT gal [dcm] [lon]
hsdSB carrying DE3 l prophage with the T7 RNA polymerase gene
(Novagen), was transformed with recombinant pRP261 plasmids. Colo-
nies obtained were used to inoculate Luria-Bertani medium containing
100 mg/ml ampicillin, and cultures were grown overnight at 378C and 250
rpm. Cultures were then diluted 1:20 in fresh medium, grown to an OD600
of 0.7 at 308C and 200 rpm, and induced by the addition of isopropyl b-D-
thiogalactopyranoside (IPTG) to 0.4 mM for an additional 3 h. Bacteria
were harvested by centrifugation at 4,000 g, resuspended in PBS containing
1 mM EDTA and 1% (vol/vol) Triton X-100, and lysed by sonication. Ly-
sates were cleared by centrifugation for 10 min at 10,000 g and 48C, and the
resulting supernatants were incubated with glutathione agarose beads (G
4510; Sigma Chemical Co.). Beads with affinity-bound proteins were
washed three times with PBS containing 1% (vol/vol) Triton X-100, and
equilibrated in 50 mM Tris-HCl (pH 8.0). Bound proteins were eluted in 50
mM Tris-HCl (pH 8.0), containing 10 mM reduced glutathione.
Recombinant MBP-plectin ABD fusion protein was expressed and pu-
rified as described above, except that amylose resin (800-21; New England
Biolabs) was used for the affinity purification, and that equilibration and
elution of the resin was in 20 mM Tris-HCl (pH 7.4), 1 mM b-mercapto-
ethanol without or with 10 mM maltose, respectively. Buffers containing
the eluted fusion proteins were exchanged by ultrafiltration using Centri-
con 10 filters (Amicon; Millipore).
Dot Blot Assay
Purified recombinant GST fusion proteins containing different fragments
of the b4 cytoplasmic domain (0.4 mg/ml) dissolved in actin polymeriza-
tion buffer (APB) (10 mM Tris-HCl, 2 mM MgCl2, 100 mM KCl, 0.5 mM
ATP, 0.1 mM b-mercaptoethanol, pH 7.5) or actin-G buffer (AGB) (10 mM
Tris-HCl, 0.2 mM CaCl2, 0.1 mM b-mercaptoethanol, pH 7.5) were pre-
cleared by centrifugation at 100,000 g for 30 minutes at 48C in a TLA 100.3
rotor (Beckman). Subsequently, protein concentration of the cleared ly-
sates was determined using Bradford protein assay. Bovine a skeletal
muscle actin (A3653; Sigma Chemical Co.) in AGB was polymerized at
4.5 mM for 1 h at room temperature. Samples were diluted to 10–30 mg/ml
in the appropriate buffer and spotted, 100 ml per well, on nitrocellulose
membrane using a Hoeffer 96 wells dot blot system (Amersham Pharma-
cia Biotech). Membrane strips were subsequently incubated in blocking
buffer (APB or AGB supplemented with 0.2% [wt/vol] heat-inactivated
BSA, and 10 mg/ml each of the protease inhibitors aprotinin, leupeptin,
and pepstatin). [35S]methionine/cysteine-labeled plectin-ABD protein was
obtained by coupled in vitro transcription/translation of pcDNA3HA-
plectin ABD DNA using the TNT® coupled reticulocyte lysate system
(Promega). Nonincorporated radiolabeled amino acids were removed
from the in vitro translation mixture using Centricon 10 filters. Purified
translation mixture (25 ml) was diluted into 3 ml of blocking buffer and in-
cubated for 3 h at room temperature with the nitrocellulose strips. The
strips were then washed three times in blocking buffer, air dried, and ex-
posed using Kodak X-Omat AR film.
Actin Cosedimentation Assay
Bovine a skeletal muscle actin (5 mM in AGB) was allowed to polymerize
in the presence of MBP-plectin ABD fusion protein (1 mM) by the addi-Geerts et al. Interaction of Plectin with b4 and the Cytoskeleton 421
tion of 0.1 vol of 103 initiation mix (20 mM MgCl2, 1 M KCl, 5 mM ATP)
for 1 h at room temperature. Polymerized actin filaments complexed with
plectin were pelleted by centrifugation for 1 h at 100,000 g and 208C, and
resuspended in APB. Actin–plectin complexes were then incubated with
10  mM of purified, precleared GST-b4 fusion proteins (as described
above) for 1 h at room temperature. Actin filaments with bound protein
were pelleted as described above, and corresponding amounts of pellet
and supernatant were analyzed by SDS-PAGE.
Results
Expression and Distribution of Hemidesmosomal 
Proteins in Immortalized MD-EBS Keratinocytes
Two immortalized keratinocyte cell lines were derived
from unrelated MD-EBS patients, and analyzed by West-
ern blot using specific antisera for the different hemides-
mosome proteins (Fig. 1). Expression of the hemidesmo-
some proteins was similar in the two MD-EBS cell lines,
but different from that in NHK cells because the MD-EBS
keratinocytes expressed b4, BP230, and BP180, but not
plectin.
Next, we analyzed the distribution of hemidesmosome
proteins in MD-EBS cells using confocal immunofluores-
cence microscopy (Fig. 2). As expected, no reaction was
found with plectin antiserum (Fig. 2 E). The integrin a6b4,
as well as BP180 and BP230 were concentrated at cell–
substrate contact sites in patch-like structures (Fig. 2, A–C
and F). This staining pattern is typical for hemidesmo-
some-like structures in cultured keratinocytes (Borradori
et al., 1998; Schaapveld et al., 1998). The extracellular
ligand of a6b4, laminin-5, was concentrated underneath
the hemidesmosome-like structures (Fig. 2 D). These ob-
servations indicate that at least on a laminin-5 matrix, ke-
ratinocytes can form hemidesmosomes in the absence of
plectin.
Expression of the Plectin-ABD in MD-EBS 
Keratinocytes Results in Its Association with both Actin 
Stress Fibers and Hemidesmosomes
Plectin contains a highly conserved NH2-terminal ABD,
and is therefore potentially capable of binding actin; yet
F-actin has not been found in association with hemidesmo-
somes. We speculated that binding of a6b4 to plectin
might prevent it from binding to F-actin, possibly by com-
peting with actin for overlapping binding sites on plectin.
To examine the subcellular distribution of the NH2-termi-
nal ABD of plectin, an expression vector carrying plectin-
ABD cDNA, a clone encoding the first 339 amino acid
residues of human epithelial plectin encompassing its
ABD fused to an HA tag, was transiently transfected in
MD-EBS cells (Fig. 3).
In the majority of cells, the plectin fragment was effi-
ciently expressed, and its staining pattern overlapped with
that of phalloidin-stained F-actin (Fig. 3, A–C). However,
in a population of z10–20% of the cells, it was also
present in basally located hemidesmosome-like clusters
not associated with F-actin (Fig. 3, D–F). Only very few
cells exclusively express the plectin fragment in hemides-
mosome-like clusters (Fig. 3, G–I).
These data suggest that the NH2 terminus of plectin is
not only capable of associating with F-actin, but also with
a6b4-containing hemidesmosome-like structures.
Expression of b4 in PA-JEB Keratinocytes Alters the 
Distribution of Plectin Compared with that of F-Actin
The above results prompted us to investigate whether the
intact plectin molecule is also capable of associating with
F-actin. Therefore, we compared its distribution with that
of F-actin in PA-JEB keratinocytes that endogenously ex-
press full-length plectin. In addition, we studied the distri-
bution of these two proteins in PA-JEB cells that stably
express the integrin a6b4 at their cell surface. In both cell
types the staining pattern of plectin with the mAb 121
against plectin/HD1 and an affinity-purified polyclonal an-
tiserum against the plectin-ABD was similar. In the PA-
JEB keratinocytes, both antibodies stained plectin dif-
fusely throughout the cytoplasm, with some enrichment of
the protein in regions where F-actin was also found to be
concentrated (Fig. 4, A–C). In general, the staining pat-
tern of plectin seen with the mAb 121 appeared more in
spots, whereas the staining produced by the polyclonal
plectin antiserum was often continuous and clearly associ-
ated with cytoskeletal elements (Fig. 4, G–I). Plectin was
only occasionally found to be associated with F-actin at
the cell periphery, where microtubules and/or intermedi-
ate filaments may be running parallel to F-actin and be
linked to it by plectin (Fig. 4, J–L) (Svitkina et al., 1996).
Association of plectin with F-actin probably also occurs at
other sites in the cell, but it may not be as easily recog-
nized there because the cytoskeletal fibers it links do not
run parallel to one another but are intertwined. Further-
more, it should be realized that the distribution of F-actin
may be different from that of plectin, because plectin can
also cross-link other cytoskeletal systems, i.e., intermedi-
ate filament with microtubules (Svitkina et al., 1996). In
PA-JEB cells that stably express the integrin a6b4, both
Figure 1. Expression of hemidesmosomal proteins in immortal-
ized MD-EBS keratinocytes. Western blot of lysates of normal
(NHK; lanes 1) and plectin-deficient (MD-EBS; lanes 2) human
keratinocytes, probed with mAb 450-11A against integrin b4
(200 kD), mAb 7A8 against plectin (.500 kD), polyclonal antise-
rum against BP230 (230 kD), or polyclonal antiserum against
BP180 (180 kD). All hemidesmosome proteins tested, except
plectin, were present in MD-EBS keratinocytes.The Journal of Cell Biology, Volume 147, 1999 422
antibodies stained hemidesmosome-like structures, which
were devoid of F-actin (Fig. 4, D–F).
These results demonstrate that plectin is associated with
the cytoskeleton, including F-actin, or with hemidesmo-
some-like structures, and that the localization of plectin
with the latter is dependent on the expression of a6b4.
Direct Interaction between the NH2 Terminus of Plectin 
and the Cytoplasmic Domain of b4
To investigate whether the NH2-terminal ABD of plectin
can interact directly with the cytoplasmic domain of the b4
integrin subunit, and to determine the binding site on b4, a
yeast two-hybrid assay was performed. The plectin-ABD
fragment was expressed as a GAL4 BD fusion, together
with one of a set of overlapping fragments of the b4 cyto-
plasmic domain (as GAL4 AD fusions) in the yeast strain
PJ69-4A. Interactions were detected by the growth of
yeast colonies on selective SC-LTHA plates (Fig. 5 A).
A high plating efficiency, indicating that the reporter
genes were efficiently expressed as a result of a strong in-
teraction between the plectin-ABD and b4, was observed
with the b41115–1457,  b41115–1382, and  b41115–1355 constructs.
The site of interaction on the b4 cytoplasmic domain could
be mapped to the first and second FNIII repeat and 27 res-
idues of the CS, as present in the b41115–1355 construct. The
b41115–1328 construct with the last 27 amino acids deleted in-
teracted only weakly with the plectin-ABD. The first
FNIII repeat itself does not bind plectin-ABD, but is nev-
ertheless essential for this binding, since its deletion in the
b41217–1328 construct results in a complete abrogation of
binding. No interaction could be found with the third or
fourth FNIII repeat, alone or when present as a pair.
Therefore, the interaction of the NH2 terminus of plectin
with b4 is specific for the first pair of FNIII repeats and 27
amino acids of the CS (amino acids 1115–1355).
The R1281W b4 Mutation Abrogates Binding to Plectin 
without Interfering with Other Protein
Interactions of b4
Recently, two patients with nonlethal PA-JEB have been
described who were either homozygous or heterozygous
for a missense mutation, i.e., a single amino acid substitu-
tion from R to W at residue 1281 of b4 (Pulkkinen et al.,
1998). Since the R to W mutation was within the binding
site for plectin mentioned above, we introduced it into
wild-type  b4 cDNA to study its effect on the binding of b4
to plectin. This was first tested in a yeast two-hybrid assay
(Fig. 5 B). The results show that b4-plectin binding was
completely abrogated by this mutation, confirming that
the second FNIII repeat of b4 is essential for binding to
plectin. We then tested whether the intramolecular in-
teraction within the wild-type b4 cytoplasmic domain,
as described previously (Schaapveld et al., 1998), was af-
fected in the b4R1281W mutant. Wild-type (b41115–1457) and
R1281W (b41115–1457*) constructs were expressed in yeast
as GAL4 AD fusions together with a GAL4 BD fusion
of  b41457–1752. Both wild-type (b41115–1457)  and mutant
(b41115–1457*) bound strongly to the b41457–1752 fusion pro-
tein, indicating that intramolecular binding could still oc-
cur in the b4R1281W mutant protein.
Next, we tested the effect of the R1281W mutation on
the function of b4 in hemidesmosome formation in im-
Figure 2. Localization of hemidesmosome proteins in immortalized MD-EBS keratinocytes. Cells were fixed, immunolabeled, and sub-
jected to confocal immunofluorescence microscopy using polyclonal antiserum against a6 (A) or b4 (B), mAb 233 against BP180 (C),
mAb 6F12 against laminin-5 (D), mAb 121 against plectin/HD1 (E), or polyclonal antiserum against BP230 (F). Results obtained for
cell lines from two different, unrelated human patients were similar; shown here are the results for one patient. All hemidesmosome
proteins tested, as well as the extracellular matrix protein laminin-5 (a ligand for the integrin a6b4), are concentrated at sites of cell–
substrate contact in patches characteristic for hemidesmosome-like clusters, except plectin, which is not expressed. Sections were fo-
cused at the cell–substrate interface. Bar, 10 mm.Geerts et al. Interaction of Plectin with b4 and the Cytoskeleton 423
mortalized keratinocytes isolated from a PA-JEB patient
who completely lacked b4 (Schaapveld et al., 1998).
PA-JEB keratinocytes were transiently transfected with
full-length wild-type b4 or b4R1281W cDNA and analyzed
by confocal immunofluorescence microscopy (Fig. 6). In
transfected PA-JEB cells, both the wild-type b4 and the
b4R1281W protein were found at the basal side of the cell in
hemidesmosome-like clusters. Whereas wild-type b4 was
colocalized with plectin, BP180, and BP230 in hemidesmo-
some-like structures (Fig. 6, A, B, and C, respectively), the
b4R1281W  protein was only colocalized with BP180 and
BP230 (Fig. 6, D–F).
Thus, the data show that plectin can directly bind b4.
The recruitment of BP180 into hemidesmosomes does not
seem to require plectin; BP180 (and BP230) and plectin
can be independently recruited by b4.
Direct Binding of both b4 and Actin to the Plectin-ABD 
and Mapping of Overlapping Sites of Interaction
The cell transfection studies described in Fig. 3 suggest
that both F-actin and b4 can bind to the plectin-ABD.
Binding of b4 to an NH2-terminal part of plectin (residues
1–1128) has been shown previously by Rezniczek et al.
(1998) using in vitro binding assays, but this interaction ap-
peared not to require the presence of the plectin-ABD,
since its deletion from a smaller plectin fragment (residues
546–1128) did not result in the abrogation of binding to b4.
To examine the binding of b4 to the plectin-ABD and the
presence of additional binding sites COOH-terminal of
the ABD, a set of overlapping fragments of the entire
plectin NH2 terminus (residues 1–1155) was generated.
Each of these was expressed in yeast as a GAL4 BD fu-
sion, together with b41115–1457 as a GAL4 AD fusion (Fig. 7
A). Binding of b41115–1457 to the plectin NH2 terminus
could only be observed for the plectin-ABD fragment that
contains residues 1–339 used in the experiments described
above.
The plectin-ABD clone contains the first 9 exons of the
plectin PLEC1 gene, including the variable exon 1c (en-
coding residues 1–65), which is specific for epithelial plec-
tin and encodes a protein sequence with no known homol-
ogies. Exons 2–8 encode the plectin-ABD (amino acid
residues 66–302), and exon 9 (residues 303–343) encodes a
unique stretch of amino acids. For further mapping of the
b4-binding site and for comparing it with that of actin,
plectin-ABD subclones were constructed and tested in a
yeast two-hybrid assay with b41115–1457 or with full-length
actin. As shown in Fig. 7 B, the plectin-ABD binds not
only b4, but also actin. The sequences encoded by exons
Figure 3. Subcellular distri-
bution of HA-tagged plectin-
ABD fragment in transfected
MD-EBS keratinocytes. 48 h
after transfection, cells were
fixed, double-immunolabeled
using mAb 12C05 against the
HA epitope (green; A, D,
and G) and polyclonal antise-
rum against b4 (red; H), and
processed for immunoflu-
orescence. TRITC-labeled
phalloidin was used to stain
F-actin (red; B and E). Com-
posite images (C, F, and I)
show the superimposition of
the green and red signals,
with areas of overlap appear-
ing yellow. Cells were visual-
ized by confocal microscopy.
The plectin protein fragment
is colocalized with actin stress
fibers, or with a6b4-contain-
ing hemidesmosome-like
basal clusters. Sections were
focused at the cell–substrate
interface. Bar, 10 mm.The Journal of Cell Biology, Volume 147, 1999 424
1c and 9 are not involved in binding to b4. Deletion of
NH2-terminal sequences within the ABD, even of only the
first four residues, disrupted binding to b4 completely,
suggesting that the first part of the ABD is essential.
COOH-terminal deletions showed that deletions extend-
ing into the ABD abrogate binding even when all three
ABS sequences (residues 72–83, 144–170, and 182–196)
were intact, showing that the last part of the ABD is also
required. Therefore, the minimal region in plectin re-
quired for binding to b4 comprises residues 65–302, i.e.,
the complete ABD.
Investigation of the binding site for actin on the same
panel of plectin fragments showed that deletion of the first
35 residues in plectin did not affect its interaction with ac-
tin, but that removal of all 64 residues encoded by exon 1c
abolished it, in contrast to the binding of b4. This could be
due to steric hindrance of the ABD in juxtaposition to the
GAL4 BD moiety present in the GAL4-plectin65–339 fusion
protein, since data in the literature do not reveal that
amino acids NH2-terminal of the ABD are required for
binding to actin in other actin-binding proteins (Fabbrizio
et al., 1993; Corrado et al., 1994). COOH-terminal dele-
tions showed that no residues COOH-terminal of the
plectin-ABD are required for binding of actin either.
However, in contrast to b4, actin could still bind when
COOH-terminal parts of the ABD were deleted up to and
including ABS3. Only deletion of ABS2 resulted in com-
plete loss of actin binding. Therefore, ABS1 and ABS2 are
sufficient to bind actin. Plectin is versatile in its binding of
actin; three different actin isoforms were tested for inter-
Figure 4. Distribution of
plectin compared with F-actin
in PA-JEB cells. PA-JEB
keratinocytes and PA-JEB
cells stably expressing the
integrin a6b4 were fixed,
double-immunolabeled us-
ing mAb 121 against plectin
(green; A, D, and G) or an
affinity-purified polyclonal
antiserum against the plec-
tin-ABD (green; H and J)
and F-actin (red; B, E, and
K), and processed for immu-
nofluorescence. Composite
images (C, F, I, and L) were
generated by superimposi-
tion of the green and red sig-
nals, with areas of overlap
appearing yellow. Cells were
visualized by confocal mi-
croscopy. In PA-JEB cells
(A–C), the staining patterns
of plectin and F-actin partly
overlapped, whereas in the
a6b4-positive cells (D–F)
plectin was exclusively local-
ized in hemidesmosome-like
basal clusters that did not
stain for F-actin. These sec-
tions (A–F) were taken at
the optical plane correspond-
ing to the cell–substrate in-
terface. In another plane of
focus (G–I), it is shown that
the two anti-plectin antibod-
ies produce a similar pattern
of staining of the cytoskele-
ton in PA-JEB keratino-
cytes. (J–L) Higher magnifi-
cation shows plectin associated
with F-actin filaments in PA-
JEB keratinocytes (arrows).
Bars: 10 mm (A, D, and G);
and 5 mm (J).Geerts et al. Interaction of Plectin with b4 and the Cytoskeleton 425
action with plectin1–339: a skeletal muscle actin, b cytoplas-
mic actin, and g cytoplasmic actin, and all effectively bind
plectin (data not shown).
In conclusion, the binding sites for b4 and actin both re-
side in the plectin-ABD. Both sites start at the beginning
of the ABD; actin binding only requires ABS1 and ABS2;
the binding of b4 also requires ABS3 and more COOH-
terminal sequences. b4 and actin do not bind to each
other; they do not interact in the yeast two-hybrid assays
(data not shown). Together, these results suggest that the
binding site for b4 overlaps with that for actin. Therefore,
only one of these proteins can bind to a single plectin mol-
ecule, binding thus being mutually exclusive.
Biochemical Evidence for Competitive Binding of b4 
and F-Actin to the Plectin-ABD
To confirm the yeast two-hybrid results described above,
an in vitro binding assay was performed. GST-b4 fusion
proteins or F-actin were spotted on nitrocellulose using a
dot blot system and the immobilized proteins were over-
laid with in vitro translated, radio-labeled plectin-ABD
protein (Fig. 8, A and B). Two different buffers were used
in the overlay assay: APB, a high-salt buffer which main-
tains F-actin in a polymerized state, and AGB, a low-salt
buffer in which F-actin can depolymerize to monomeric
G-actin. The plectin-ABD strongly bound F-actin, GST-
b41115–1382, but not GST-b41115–1382* (R1281W) or GST-
b41457–1752, which is in accordance with the yeast two-
hybrid assay results (Figs. 5 and 7). No significant binding
was found to GST-b41115–1328, although this mutant protein
interacted weakly with the plectin-ABD in the yeast two-
hybrid assay. These different results may reflect a differ-
ence in the sensitivity of the two assays, with the yeast two-
hybrid assay being more sensitive than the dot blot assay.
Consistent with the absence of binding of the b41115–1328
mutant to plectin in the dot blot assay, the mutant protein
was also unable to induce a redistribution of plectin in cell
transfection experiments (Niessen et al., 1997b; Schaapveld
et al., 1998). Binding of the plectin-ABD to the GST-
b41115–1382 fusion protein was stronger in the presence of
low salt (AGB). Thus, binding is probably ionic in nature,
explaining why charged residues, i.e., R1281, are impor-
tant for b4–plectin interactions. In contrast, binding of the
plectin-ABD to actin was significantly weaker in the pres-
ence of low salt.
To obtain evidence that b4 and F-actin indeed compete
for binding to the plectin-ABD, we performed an in vitro
competition assay. F-actin, polymerized in the presence of
MBP-plectin-ABD fusion protein, was incubated with a
10-fold molar excess of soluble GST fusion proteins. Then
the F-actin complexes were precipitated by centrifugation
and the supernatant and pellet were collected separately
(Fig. 8 C). In the absence of GST-b4 fusion protein, or in
the presence of GST-b41115–1328 or GST-b41115–1382*, all
MBP-plectin protein was found in the pellet together with
actin. However, in the presence of GST-b41115–1382, about
half of the MBP-plectin protein appeared in the superna-
tant due to binding to the soluble GST-b4 fusion protein.
The results show that b4 can efficiently compete with
F-actin for binding to the plectin-ABD.
The Plectin COOH Terminus Interacts with 
Intermediate Filament Proteins, but Not with b4
The results presented so far provide evidence for a role of
the NH2 terminus of plectin in the binding of both F-actin
and b4. To rule out a role for the COOH terminus of plec-
tin more precisely of its globular repeat domains, we also
tested cDNA clones encoding this part of the plectin mole-
cule. Since earlier studies (Wiche et al., 1993; Nikolic et al.,
1996) had indicated a role for sequences at the end of the
R5 domain in binding to intermediate filament proteins,
plectin fragments containing this putative IFBD were also
tested for interaction with the keratins 5, 8, 14, and 18, and
with vimentin and GFAP. Two plectin cDNA clones were
tested in the yeast two-hybrid assay. One encoded most of
R5, the complete R6, and the COOH tail, and the other
encoded most of R6 and the COOH tail. They were ex-
pressed in yeast as GAL4 BD fusion proteins together
with GAL4 AD fusion proteins of b41115–1457, b41320–1668, or
b41457–1752, or of different intermediate filament proteins
(Fig. 9). No interaction was found between the plectin
fragments and any of the b4 fragments tested. However,
specific interaction of the larger plectin fragment, which
contained the IFBD at the end of R5, could be detected
with different types of intermediate filament proteins.
Figure 5. Mapping of the binding site between the NH2-terminal
part of plectin and the cytoplasmic domain of b4 and of the inter-
nal folding of the b4 cytoplasmic domain by yeast two-hybrid
analysis. (A) Cotransformation of yeast host strain PJ69-4A with
pAS2-plectin1–339 and one each of the listed pACT2-b4 constructs
or empty pACT2 vector to determine the plectin-b4 interaction
site. (B) Cotransformation with pAS2-plectin1–339 or pAS2-
b41457–1752, and pACT2-b41115–1457  (wild-type) or -b41115–1457*
(R1281W) to characterize plectin-b4 binding and the internal
folding of the b4 cytoplasmic domain. Transformation mixtures
were spread on SC-LT and SC-LTHA plates and grown for 12 d
at 308C. Plating efficiency on selective SC-LTHA plates is ex-
pressed as a percentage of plating efficiency on nonselective SC-
LT plates of the same transformation. 11, .50%;  1,  .50%
(slow-growing colonies); 6, 5–25%; 2, 0%. Plates were scored
after 6 and 12 d of growth. Slow-growing colonies could only be
scored after 12 d of growth. Plating efficiencies of ,25% always
represented slow-growing colonies. All efficiencies listed repre-
sent an average of multiple independent transformations on at
least three separate occasions.The Journal of Cell Biology, Volume 147, 1999 426
Binding was observed with keratins 14 and 18, but not with
keratins 5 or 8, and with both vimentin and GFAP.
Thus, the results show that the plectin COOH terminus
has no function in the binding to the b4 cytoplasmic do-
main, but confirm the presence of a distinct intermediate
filament protein–binding site in the plectin domain R5,
which we have shown to bind the type I and III, but not
type II intermediate filament proteins.
The Plectin-IFBD Associates with the Intermediate 
Filament Cytoskeleton in Plectin-deficient
MD-EBS Keratinocytes
To investigate whether the plectin-IFBD fragment that in-
teracts with intermediate filament proteins in a yeast two-
hybrid assay also associates with intermediate filaments in
keratinocytes, we transiently transfected MD-EBS cells
with an expression vector containing the plectin-IFBD
fused to an HA tag, and analyzed the results by confocal
immunofluorescence microscopy (Fig. 10). In contrast to
normal keratinocytes in vivo, which do not express vimen-
tin but only keratins, the EBS-MD keratinocytes coex-
pressed vimentin and keratin intermediate filaments. In
cells expressing plectin-IFBD, the HA-tagged protein was
found to be distributed together with keratins in delicate
filamentous structures (Fig. 10, D–F). Although the ex-
pression of plectin-IFBD had no apparent effect on the
keratin intermediate filament network, in many cells it in-
duced a collapse of the vimentin network into dense clus-
ters around the nucleus (Fig. 10, G–I). Colocalization of
these two proteins in filamentous structures was only ob-
served in a few cells (data not shown). The dramatic effect
of the plectin-IFBD on the integrity of the vimentin inter-
mediate filament network suggests that it interferes with
another protein with properties similar to plectin that me-
diates the anchorage of these filaments at distal or periph-
eral sites in the cell. It may also indicate that plectin-IFBD
binds more strongly to vimentin than to keratins. The
a6b4 integrin was always present in basally located hemi-
desmosome-like clusters, and showed no obvious colocal-
ization with plectin-IFBD (Fig 10, A–C). These results
suggest that in a normal situation, when the intact plectin
protein is present, it helps to provide a scaffold for the vi-
mentin cytoskeleton.
Figure 6. Localization of hemidesmosomal components in PA-JEB keratinocytes transiently transfected with cDNAs encoding full-
length wild-type b4 or b4R1281W. Cells were fixed, double-immunolabeled using polyclonal antiserum against a6 (red; A–F) and mAb
121 against plectin/HD1 (green; A and D), mAb 233 against BP180 (green; B and E), or polyclonal antiserum against BP230 (green; C
and F), and processed for immunofluorescence. Cells were visualized by confocal microscopy. Expression of b4 results in the formation
of hemidesmosome-like structures at sites of cell–substrate contact, in which a6b4 is concentrated, as shown by staining for a6. Similar
results were obtained when instead of the anti-a6 antiserum, a polyclonal antiserum against b4 was used. The wild-type integrin a6b4
(A–C) is colocalized with plectin, BP180, and BP230. The mutant integrin a6b4R1281W is not colocalized with plectin (D), but is colocal-
ized with BP180 (E) and BP230 (F). Sections were focused at the cell–substrate interface. Bar, 10 mm.Geerts et al. Interaction of Plectin with b4 and the Cytoskeleton 427
The Integrin a6b4 Organizes the Vimentin 
Intermediate Filament Network through Plectin upon 
Expression in PA-JEB Keratinocytes
To study a possible indirect role for the integrin a6b4 (via
plectin) in the organization of the vimentin intermediate
filament network, immortalized b4-deficient PA-JEB ke-
ratinocytes were transiently transfected with cDNAs en-
coding wild-type or mutant b4 and used in confocal immu-
nofluorescence microscopy (Fig. 11). In nontransfected
cells, vimentin is present in rather loose filamentous net-
works throughout the cytoplasm, but in cells expressing b4
it was also detected in dense basally located clusters colo-
calized with a6b4 (Fig. 11, A–C). These results show that
expression of b4 leads to a reorganization of the vimentin
intermediate filament network. This most likely occurs by
binding of b4 to the ABD in the plectin NH2 terminus, ac-
companied by binding of vimentin to the IFBD in its
COOH terminus. The effect of b4 on the vimentin net-
work would then be indirect and dependent on the binding
of b4 to plectin.
Further evidence for this was obtained by transfection
of one mutant b4 protein, b41355, that can efficiently bind
plectin, and one b4 mutant, b41328, that binds plectin in
yeast two-hybrid assays, but much less efficiently. In cells
transfected with b41355 cDNA, the b4 protein fragment was
present in basal hemidesmosome-like clusters colocalized
with vimentin (Fig. 11, D–F). The b41328 mutant was also
found in basal clusters, but it only occasionally colocalized
with vimentin (Fig. 11, G–I).
These results show that b4 is capable of organizing the
vimentin intermediate filament cytoskeleton. It does so in-
directly, via plectin, since only b4 mutants that contained
the plectin binding site (like b41355) were capable of orga-
nizing vimentin filaments into hemidesmosome-like basal
clusters. Since this b4 mutant cannot recruit BP180 or
BP230 (Schaapveld et al., 1998), the BP proteins do not
seem to play a role in this process.
Discussion
Plectin-deficient MD-EBS Keratinocytes Form 
Hemidesmosome-like Structures
We have established immortalized keratinocytes from a
human MD-EBS patient. In these cell lines, hemidesmo-
some-like clusters containing a6b4, BP180, and BP230
(but not plectin) were present at the basal side of the MD-
EBS cells at sites of cell–substratum contact, as was the
ligand for a6b4 laminin-5. Except for the absence of plec-
tin, these hemidesmosome-like clusters are indistinguish-
able from hemidesmosomes in NHK cells (Borradori et al.,
1998; Schaapveld et al., 1998). FACS® analysis of the MD-
EBS cells gave expression levels of the a6 and b4 subunits
that are about half of those in NHK cells (data not shown).
In plectin-deficient null-mutant mice, hemidesmosomes
were also present, but their number as well as the amount
of b4 at the basal side of the epidermal cells was reduced,
indicating an important role for plectin in maintaining the
Figure 7. Mapping of the in-
teraction site for b4 and for
actin on the NH2 terminus of
plectin by yeast two-hybrid
analysis. (A) Cotransforma-
tion of yeast host strain PJ69-
4A with one each of the
pAS2-plectin subclones listed
together with pACT2-b41115–1457
to determine the interaction
site for b4 on plectin (A) and
with one each of the pAS2-
plectin ABD subclones listed
together with pACT2-b41115–1457
or actin for a comparison of
the  b4- and actin-binding
sites on plectin (B). The re-
sults shown for plectin36–302,
plectin36–236, plectin36–181, and
plectin36–142 are identical for
those obtained with two sets
of four similar subclones
starting at residues 1 or 5, re-
spectively. The results shown
are for b cytoplasmic actin.
No binding was found be-
tween pACT2-b41115–1457 and
pAS2-actin (data not shown).
Details are as for Fig. 5.The Journal of Cell Biology, Volume 147, 1999 428
integrity of hemidesmosomes (Andrä et al., 1997). Evi-
dently, normal basal localization of a6b4 into hemidesmo-
some-like clusters can occur in MD-EBS keratinocytes,
but plectin might have a role in retaining a6b4 at the cell
surface. It should be noted that hemidesmosome stability
and/or the localization of hemidesmosome proteins is
probably influenced by mechanical stress in the epidermis
of the null-mutant mice. The resistance to mechanical
stress of the hemidesmosomes in the MD-EBS kerati-
nocytes has not yet been tested.
Competitive Binding of b4 and Actin to a Single Binding 
Site on the Plectin-ABD
Expression of a plectin fragment containing the ABD in
MD-EBS keratinocytes resulted in two different types of
subcellular distribution: colocalization with actin stress
fibers or a patch-like organization which is typical for
hemidesmosomes. The decoration of actin stress fibers
was also found in similar experiments with plectin in fibro-
blasts (Andrä et al., 1998) and with other proteins of the
spectrin family (Hemmings et al., 1992; Winder et al.,
1995; Yang et al., 1996; Hanein et al., 1997). However, a
unique feature of the ABD of plectin, is that in kerati-
nocytes it can also dictate the localization of plectin into
hemidesmosomes, together with a6b4. Direct binding of
b4 to the plectin-ABD was demonstrated using yeast two-
hybrid and dot blot overlay assays. In addition, we showed
that b4 can effectively compete plectin-ABD out of an
F-actin–plectin complex in an in vitro actin cosedimenta-
tion assay. This suggests that competition between b4 and
actin for overlapping binding sites on the plectin-ABD is
the molecular basis for the relocalization of plectin from
actin-containing cytoskeletal complexes (like actin stress
fibers or focal contacts) to b4-containing hemidesmo-
somes at the basal side of keratinocytes when b4 is ex-
pressed. It is not yet clear whether these processes are also
regulated at a different level, i.e., by protein phosphoryla-
tion, or by a regulation of actin filament dynamics via
phosphatidylinositol 4,5-bisphosphate (PIP2), for example
(Andrä et al., 1998).
Since hemidesmosomes are generally seen as stable ad-
Figure 8. Dot blot overlay
and actin sedimentation as-
say of recombinant purified
b4 protein fragments with
radiolabeled plectin-ABD
fragment. (A) SDS-PAGE of
4 ng in vitro translated [35S]-
methionine/cysteine-labeled
HA-tagged plectin-ABD
protein (40 kD). Auto-
radiogram. (B) Recombinant
purified GST fusion pro-
teins  encoding  b41115–1328,
b41115–1382 (wild-type se-
quence),  b41115–1382* (R1281W),
b41457–1752 (3 mg each), or
GST alone (2 mg), and puri-
fied F-actin (1, 2, or 3 mg)
were  immobilized on nitro-
cellulose by dot blotting and
incubated with 100 ng
[35S]methionine/cysteine-
labeled plectin-ABD in 3 ml
APB or AGB (upper and
middle lanes, respectively).
Protein loading was verified
by amido-black staining (bot-
tom lanes). The GST protein
alone does not bind to plec-
tin-ABD. (C) Actin fila-
ments polymerized in the
presence of and complexed
with MBP-plectin ABD fu-
sion protein were incubated
with a 10-fold molar excess
of GST fusion proteins en-
coding  b41115–1382 (lanes 1 and
2), b41115–1382* (lanes 3 and 4),
b41115–1328 (lanes 5 and 6), or
no GST fusion protein (lanes 7 and 8). The F-actin complexes were then isolated by centrifugation, after which supernatant (S; odd-
numbered lanes) and pellet (P; even-numbered lanes) were isolated and analyzed using SDS-PAGE. Proteins were visualized using
Coomassie brilliant blue staining.Geerts et al. Interaction of Plectin with b4 and the Cytoskeleton 429
hesion complexes that are less compatible with cell motil-
ity than the actin structures, it is clear that plectin recruit-
ment into hemidesmosomes might represent a pivotal
factor in adhesion and motility properties of epithelial
cells.
b4 Contains a Single Binding Site for Plectin
In a recent study, two distinct plectin-binding sites were
identified on the b4 cytoplasmic domain: one that encom-
passes the first two FNIII repeats and the CS (residues
1126–1457), and another that contains the second pair of
FNIII repeats and the COOH terminus (residues 1457–
1752). NH2-terminal fragments of epithelial rat plectin
(both with and without the ABD) were found to interact
with both binding sites on b4 in vitro in overlay assays, as
well as in vivo by transient transfection of rat kangaroo
Ptk2 cells and hemidesmosome-forming 804G rat bladder
carcinoma cells, in which b4 and plectin protein fragments
were shown to be colocalized mainly in dense perinuclear
structures in the cytoplasm (Rezniczek et al., 1998).
Previously, we have identified a region on the b4 cyto-
plasmic domain, in the first pair of FNIII repeats and the
beginning of the CS (within residues 1115–1355) that is in-
volved in the formation of a complex with plectin and its
recruitment to hemidesmosomes (Niessen et al., 1997a,b;
Schaapveld et al., 1998). In this study, we confirmed the
presence of the NH2-terminal plectin-binding site on the
b4 protein, and mapped it to residues 1217–1355. No evi-
dence was found for the more COOH-terminal binding
site reported by Rezniczek et al. (1998). Full-length b4
containing the amino acid mutation R1281W, in marked
contrast to wild-type b4 (Schaapveld et al., 1998), no
longer recruited plectin into basal hemidesmosome-like
clusters after being expressed in PA-JEB keratinocytes.
This strongly suggests that only the NH2-terminal plectin-
binding site on b4 is required for the proper localization of
plectin into hemidesmosomes.
Another difference with the results obtained by Reznic-
zek et al. (1998) is that we located the binding site for b4 in
the plectin-ABD and were not able to demonstrate inter-
action of b4 with NH2-terminal fragments of plectin from
which the ABD is absent. Nevertheless, it remains possi-
ble that sequences downstream of the ABD, although not
able to mediate binding by themselves, could enhance the
binding of the ABD to b4. Such a scenario of cooperative
binding may proffer an explanation for the finding that in
the transfected MD-EBS cells, the plectin-ABD alone is
found to be primarily colocalized with F-actin.
However, the discrepant results could also stem from
the fact that Rezniczek et al. (1998) used denatured pro-
teins for the in vitro overlay experiments, whereas the b4
cytoplasmic domain in vivo is most probably intricately
folded (Rezniczek et al., 1998; Schaapveld et al., 1998).
Our concern with the cell transfection experiments pre-
sented by these authors is that overexpression of the b4
protein fragments could affect their localization and cause
them to aggregate with other cytoplasmic structures, as
has been described previously for proteins expressed at
high levels (Johnston et al., 1998). In our studies, the b4
clones used for cell transfections contain the complete ex-
tracellular and transmembrane regions, and therefore the
expression of b4 at the basal cell surface (the physiological
location for a6b4) is limited by the amount of endogenous
integrin a6 subunit.
Plectin and BP180 Can Bind b4 in an
Independent Manner
Reports of a decreased basal localization of BP180 in epi-
dermal cells of a human MD-EBS patient (Gache et al.,
1996) and of an interaction of the BP180 cytoplasmic do-
main with the plectin COOH terminus in a yeast two-
hybrid experiment (Aho and Uitto, 1997) suggested a role
for plectin in the recruitment of BP180 into hemidesmo-
somes. Previously, we provided evidence for this by re-
porting on the basal localization of BP180 in b4-deficient
PA-JEB keratinocytes, in which mutant b4 proteins were
transiently expressed. Two mutant b4 proteins that could
not recruit plectin were also incapable of localizing BP180,
whereas their recruitment of BP230 was severely impaired
(Schaapveld et al., 1998).
However, results presented in this paper demonstrate
that in MD-EBS keratinocytes, both BP180 and BP230
are colocalized with a6b4 in basal hemidesmosome-like
clusters in the absence of plectin. Furthermore, we have
found that when expressed in PA-JEB keratinocytes, the
b4R1281W mutant was unable to bind plectin, but could re-
cruit BP180 and BP230 into hemidesmosome-like clusters.
Finally, no interaction could be detected between the
COOH-terminal fragments of plectin used in this study
and the complete BP180 cytoplasmic domain in a yeast
two-hybrid assay (data not shown).
Figure 9. Mapping of the interaction site between the COOH
terminus of plectin and the cytoplasmic domain of b4 and of full-
length intermediate filament proteins by yeast two-hybrid analy-
sis. Yeast host strain PJ69-4A was cotransformed with pAS2-
plectin and one each of the listed pACT2-IF or pACT2-b4
subclone constructs, or with empty pACT2 vector to determine
the interaction sites between plectin and b4 or intermediate fila-
ment proteins. The plectin R5-R6 clone encodes amino acid resi-
dues 4068–4687 of mouse plectin (containing most of repeat R5,
repeat R6, and the COOH tail), the plectin R6 clone encodes res-
idues 4351–4574 of human plectin (most of repeat R6 and the
COOH tail). Similar results as for the human plectin R6 clone
were obtained with a mouse plectin clone encoding residues
4206–4687 (part of repeat R5, repeat R6, and the COOH tail;
data not shown). Details are as for Fig. 5.The Journal of Cell Biology, Volume 147, 1999 430
We reasoned that the two b4 mutant proteins used in
our previous study, b4D1219–1319, in which the complete sec-
ond FNIII repeat had been deleted, and b4D17, in which
amino acids 1249–1265 of the second FNIII repeat are ab-
sent (Vidal et al., 1995), were incorrectly folded in such a
way that the binding site for BP180 on b4 was rendered
dysfunctional. There is evidence for an intramolecular
folding in vitro of the b4 cytoplasmic domain (Rezniczek
et al., 1998; Schaapveld et al., 1998), in which the COOH-
terminal part of the b4 cytoplasmic domain could fold
back and bind close to the first pair of FNIII repeats. If so,
improper folding of the first pair of FNIII repeats could
have an effect on the folding of the second pair of FNIII
repeats, where the binding site for BP180 is localized. In
the b4R1281W mutant, this intramolecular association is still
intact. We conclude that binding of b4 to plectin and
BP180 most probably occurs independently.
An Arginine to Tryptophan Substitution in b4 Results 
in a JEB Rather than an MD-EBS Phenotype
From our data it is expected that a patient who is homozy-
gous for the R to W mutation at residue 1281 in b4, would
have a phenotype similar to that of plectin-deficient pa-
tients, i.e., EBS. However, a b4 patient diagnosed to be
homozygous for this mutation had a mild form of JEB
(Pulkkinen et al., 1998). Possibly, the R1281W mutation is
responsible for the JEB phenotype by preventing the
proper expression of a6b4 at the cell surface, thereby com-
promising the adhesion function of the cell. A role for
plectin in facilitating or maintaining high surface levels of
a6b4 is suggested, because as mentioned previously, in the
two MD-EBS cell lines used in this study a reduction in
the levels of a6b4 has been observed. Indeed, the expres-
sion of a6b4 in the patient, although clearly detectable,
was found to be diminished. In skeletal muscles, plectin is
probably involved in connecting the actin filaments to in-
termediate filaments. These tissues do not express the in-
tegrin a6b4, and therefore a muscle phenotype is not ex-
pected in a patient homozygous for the R to W mutation.
Our results from transfection experiments with the
b4D17 (Schaapveld et al., 1998) and b4R1281W mutants (this
study), which are both mutations identified in patients
(Vidal et al., 1995; Pulkkinen et al., 1998), show that differ-
Figure 10. Subcellular distri-
bution of HA-tagged plectin-
IFBD fragment in MD-EBS
keratinocytes after transient
transfection. Cells were tran-
siently transfected with an
HA-tagged plectin R5-R6
cDNA construct. Cells were
fixed, double-immunolabeled
using polyclonal antiserum
HA-11 against the HA tag
(green; A, D, and G) and a
mixture of mAbs 58XB4 and
4.3E1 against b4 (red; B), a
mixture of mAbs SPK-14 and
KL1 against keratins (red;
E), or mAb V9 against vi-
mentin (red; H), and pro-
cessed for immunofluores-
cence. Composite images (C,
F, and I) were generated by
superimposition of the green
and red signals, with areas of
overlap appearing yellow.
Cells were visualized by con-
focal microscopy. The plec-
tin-IFBD protein fragment is
exclusively found in cytoplas-
mic filament structures (A,
D, and G). a6b4 is present in
basally located hemidesmo-
some-like clusters (B), to-
gether with the plectin-IFBD
(C). Keratins are observed in
a dense cytoplasmic filament
network (E), which is deco-
rated by the plectin-IFBD
(F). Expression of the IFBD-
fragment of plectin causes a
collapse of the vimentin fila-
ment network (H and I). Bar,
10 mm.Geerts et al. Interaction of Plectin with b4 and the Cytoskeleton 431
ences in the severity of the disease in different PA-JEB
patients can also result from an impaired function of b4 to
recruit BP180 and BP230 into hemidesmosomes. Both mu-
tants are unable to recruit plectin, but only the b4D17 pro-
tein had also lost its ability to interact with BP180. Experi-
ments like those described in this paper could be valuable
for providing insight into the molecular processes involved
in EB disease.
The Plectin COOH Terminus Binds to the Intermediate 
Filament Cytoskeleton, Not to
Hemidesmosome Proteins
We show that COOH-terminal plectin fragments can di-
rectly bind to various types of intermediate filament pro-
teins in a yeast two-hybrid assay. Furthermore, upon ex-
pression in MD-EBS keratinocytes, the plectin-IFBD
fragment is found localized along keratin intermediate fil-
aments and induces a collapse of the vimentin network.
This latter finding is of interest because it suggests a spe-
cific role for this domain of plectin in stabilizing the vi-
mentin intermediate filament network and its association
with hemidesmosomes. The significance of anchoring vi-
mentin to hemidesmosomes (seen in the PA-JEB cells af-
ter transfection with b4 cDNA) is not clear, since kerati-
nocytes normally do not express this intermediate filament
protein, although it is sometimes seen in rapidly migrating
cells. However, it may be more important for cells that are
a6b4-positive and express type III intermediate filaments,
such as certain types of fibroblasts and endothelial cells. In
fact, it has been shown recently that vimentin is associated
with the b4 subunit of the a6b4 integrin in endothelial
cells (Homan et al., 1998). Coexpression of vimentin with
keratins is observed in many epithelial tumors, and has
been linked to metastatic disease (Fischer et al., 1989;
Raymond and Leong, 1989). It is tempting to speculate
that in transformed keratinocytes the expression of vimen-
tin may alter the interaction between hemidesmosomes
and keratins, and that this may play a role in the develop-
ment of metastases.
In the yeast two-hybrid assay, the binding of plectin to
vimentin depends on the presence of the plectin-IFBD (lo-
Figure 11. Subcellular dis-
tribution of wild-type and
mutant  b4 and study of the
effect of b4 expression on
the vimentin intermediate
filament network in trans-
fected PA-JEB kerati-
nocytes. PA-JEB cells were
transfected with cDNA en-
coding full-length b4 (A–C),
COOH-terminal deletion
mutants  b41355  (D–F), and
b41328 (G–I). Cells were
fixed, double-immunola-
beled, and processed for
confocal immunofluores-
cence microscopy using
polyclonal antiserum against
the a6 subunit (green; A, D,
and G), or mAb V9 against
vimentin (red; B, E, and H).
Composite images (C, F,
and I) were generated by su-
perimposition of the green
and red signals, with areas of
overlap appearing yellow.
Expression of wild-type full-
length b4 results in the for-
mation of hemidesmosome-
like structures, in which
a6b4 is concentrated at sites
of cell–substrate contact, as
is shown by staining for a6,
and codistributes with the
vimentin network, most
probably dependent upon its
binding to plectin (A–C).
The b41355  mutant protein,
which efficiently binds to
plectin, is found colocalized
with the vimentin network
(D–F). The b41328 mutant protein, which can only bind plectin with low efficiency in vitro, was only very occasionally found to be
colocalized with vimentin (G–I). Bar, 10 mm.The Journal of Cell Biology, Volume 147, 1999 432
cated at the end of domain R5), first identified by Wiche
and co-workers (Foisner et al., 1988, 1991), since clones
missing this region do not interact with this intermediate
filament protein. In addition, plectin binds the type I (or
acidic) keratins 14 and 18, and the type III intermediate
filament protein GFAP. The type II (or basic) keratins 5
and 8 do not bind, which for the first time demonstrates
specificity of the binding of plectin to keratins. In a previ-
ous study (Foisner et al., 1988) a mixture of keratins was
used, and thus binding to particular keratins could not be
distinguished. Since the crucial region in the plectin-IFBD
(Nikolic et al., 1996) is strongly basic, it is suggested that
binding to the acidic type I keratins is ionic in nature.
In vivo keratin filaments are exclusively composed of
heterodimers, i.e., specific combinations of a type I and a
type II monomer. Keratin 5 dimerizes with keratin 14 and
keratin 8 with keratin 18. In the yeast two-hybrid assay,
only a single keratin was available for interaction with the
plectin-IFBD and since keratins cannot form stable ho-
mopolymers (Quinlan et al., 1994), plectin most probably
is capable of binding monomeric keratin. The fact that
plectin associates with intermediate filaments demon-
strates that in the formation of keratin dimers the binding
site for plectin is not blocked. The association of plectin
with intermediate filament proteins can be influenced by
specific plectin phosphorylation events. Together, these
findings support the idea that plectin-intermediate fila-
ment association is a well-regulated event in the organiza-
tion of the cytoskeleton (for review see Wiche, 1998).
In apparent contrast with the findings published by
Rezniczek et al. (1998), which described a binding site for
b4 on a COOH-terminal fragment of plectin starting with
the last part of domain R5 using in vitro binding assays, we
were not able to detect binding of the plectin fragment
containing these sequences to the b4 cytoplasmic domain
(see previous section for a possible explanation); no inter-
action was found between GAL4–plectin and GAL4–b4
fusion proteins in a yeast two-hybrid assay and similarly,
plectin-IFBD protein was not found to be colocalized with
a6b4 in hemidesmosome-like basal clusters upon expres-
sion in MD-EBS keratinocytes. Thus, the COOH terminus
of plectin appears to be primarily involved in the binding
of intermediate filament proteins, rather than of b4.
Plectin as a Linker Protein
Plectin can bind at least three different actin isoforms with
similar efficiencies (data not shown), in contrast to related
actin-binding proteins like utrophin, which have different
binding efficiencies for various actin isoforms (Winder et al.,
1995). Actin isoforms are expressed at specific stages of
development and only in certain tissues, and can have spe-
cific subcellular distributions within one cell (for review
see Gunning et al., 1998). Thus, plectin can act as an actin
linker protein in all these tissues and cells.
Like plectin, other plakins also show specificity in bind-
ing intermediate filament proteins: BP230 binds neurofila-
ment proteins but not vimentin (Yang et al., 1996; Leung
et al., 1999), and desmoplakin (a desmosomal plakin) has a
much higher affinity for type II keratins than for type I
keratins or vimentin (Stappenbeck et al., 1993; Kouklis et al.,
1994; Meng et al., 1997). The different specificities of these
plakins for the various intermediate filament proteins sug-
gest slightly divergent functions in the organization of the
intermediate filament network. In this respect, it is inter-
esting to note that plectin cannot compensate for the loss
of BP230, or vice versa, in human patients or null-mutant
mice deficient for one of these proteins (Guo et al., 1995;
Gache et al. 1996; Andrä et al., 1997).
The data presented in this study conclusively prove that
the NH2 terminus of plectin is involved in interactions with
actin filaments or with b4 and its COOH terminus in bind-
ing to intermediate filament proteins. A similar organiza-
tion of binding sites has been found for desmoplakin: its
NH2 terminus binds to proteins in the adhesion complex
(Bornslaeger et al., 1996; Kowalczyk et al., 1997; Smith
and Fuchs, 1998), whereas its COOH terminus interacts
with intermediate filament proteins (Stappenbeck et al.,
1993; Kouklis et al., 1994; Meng et al., 1997). The assign-
ment of specific and distinct protein-binding sites on the
plectin molecule and the study of the regulation of plectin-
binding events will allow a more detailed analysis of its
function in interlinking adhesion complexes and the intra-
cellular filament networks.
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